Clinical Trial Update: Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel [NA]

View source ↗

Summary

This document provides an update on a Phase I clinical trial evaluating the combination of Anlotinib with pemetrexed or with docetaxel in patients with non-squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• DOCETAXEL (DOCETAXEL)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Non-squamous Non-small Cell Lung Cancer | NA | Status: UNKNOWN